Should albumin be used in all patients with spontaneous bacterial peritonitis?

Canadian Journal of Gastroenterology

Volumn 25, Issue 7, 2011, Pages 373-376

  Narula, Neeraj ^a   Tsoi, Keith ^a   Marshall, John K ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

Albumin; Ascites; Colloid; SBP; Spontaneous bacterial peritonitis; Volume expansion

Indexed keywords

ALBUMIN; BILIRUBIN; CEFOTAXIME; CEFTRIAXONE; CREATININE; DEXTRAN; ENDOTOXIN; HETASTARCH; INTERLEUKIN 6; NITRIC OXIDE; POLYGELINE; TUMOR NECROSIS FACTOR ALPHA; ALBUMINOID; PLASMA SUBSTITUTE;

ADD ON THERAPY; ANTIBIOTIC THERAPY; ARTERY PERFUSION; ASCITES FLUID; BACTERIAL PERITONITIS; BACTERIAL TRANSLOCATION; BILIRUBIN BLOOD LEVEL; BLOOD VOLUME; CREATININE BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG HALF LIFE; EMBASE; HEART OUTPUT; HEART RIGHT ATRIUM PRESSURE; HIGH RISK PATIENT; HIGH RISK POPULATION; HUMAN; ISCHEMIA; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY PERFUSION; LIVER CIRRHOSIS; LIVER CLEARANCE; LIVER FUNCTION; LOW DRUG DOSE; LUNG ARTERY PRESSURE; LUNG PRESSURE; MEAN ARTERIAL PRESSURE; MEDLINE; MORTALITY; PATHOPHYSIOLOGY; PEER REVIEW; PLASMA RENIN ACTIVITY; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SPONTANEOUS BACTERIAL PERITONITIS; SURVIVAL; SYSTEMATIC REVIEW; SYSTEMIC CIRCULATION; SYSTEMIC VASCULAR RESISTANCE; UREA NITROGEN BLOOD LEVEL; VASODILATATION; BLOOD; PERITONITIS;

ALBUMINS; BILIRUBIN; HUMANS; KIDNEY DISEASES; LIVER CIRRHOSIS; PERITONITIS; PLASMA SUBSTITUTES; RENAL INSUFFICIENCY;

EID: 80053079937     PISSN: 08357900     EISSN: None     Source Type: Journal    
DOI: 10.1155/2011/586702     Document Type: Review

References (23)

1. Caruntu F, Benea L. Spontaneous bacterial peritonitis: Pathogenesis, diagnosis, treatment. J Gastrointest Liver Dis 2006;15:51-6. (Pubitemid 43845269)
2. Koulaouzidis A, Bhat S, Saeed A. Spontaneous bacterial peritonitis. World J Gastroenterol 2009;15:1042-9.
3. Terg R, Gadano A, Cartier M, et al. Serum creatinine and bilirubin predict renal failure and mortality in patients with spontaneous bacterial peritonitis: A retrospective study. Liver Int 2009;29:415-9.
4. Peters T Jr. Serum albumin. Adv Protein Chem 1997;45:153-203.
5. Laffi G, Gentilini P, Romanelli R, La Villa G. Is the use of albumin of value in the treatment of ascites in cirrhosis? The case in favour. Dig Liver Dis 2003;35:660-3. (Pubitemid 41110879)
6. Gines P, Tito L, Arroyo V, et al. Randomized comparative study of therapeutic paracentesis with and without intravenous albumin in cirrhosis. Gastroenterology 1988;94:1493-502.
7. Navasa M, Follo A, Filella X, et al. Tumor necrosis factor and interleukin-6 in spontaneous bacterial peritonitis in cirrhosis: Relationship with the development of renal impairment and mortality. Hepatology 1998;27:1227-32. (Pubitemid 28227848)
8. Blendis L, Wong F. Excess nitric oxide in pre-ascites: Another piece in the puzzle. Am J Gastroenterol 2002;97:2383-90.
9. Van Erpecum K. Ascites and spontaneous bacterial peritonitis in patients with liver cirrhosis. Scand J Gastroenterol 2006;243(Suppl):79-84. (Pubitemid 43941070)
10. Finkel M, Oddis C, Jacob T, Watkins S, Hattler B, Simmons R. Negative inotropic effects of cytokines on the heart mediated by nitric oxide. Science 1992;257:387-9.
11. Evans T. Albumin as a drug-biological effects of albumin unrelated to oncotic pressure. Aliment Pharmacol Ther 2002;16:6-11. (Pubitemid 41759557)
12. Fernandez J, Navasa M, Garcia-Pagan JC, et al. Effect of intravenous albumin on systemic and hepatic hemodynamics and vasoactive neurohormonal systems in patients with cirrhosis and spontaneous bacterial peritonitis. J Hepatol 2004;41:384-90. (Pubitemid 39158747)
13. Sort P, Navasa M, Arroyo V, et al. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999;341:403-9. (Pubitemid 29362513)
14. Xue H, Lin B, Mo J, Li J. Effect of albumin infusion on preventing deterioration of renal function in patients with spontaneous bacterial peritonitis. Chin J Dig Dis 2002;3:32-4. (Pubitemid 34211179)
15. Sigal SH, Stanca CM, Fernandez J, Arroyo V, Navasa M. Restricted use of albumin for spontaneous bacterial peritonitis. Gut 2007;56:597-9. (Pubitemid 46580522)
16. Poca M, Concepcion M, Casas M, et al. Renal failure and mortality in cirrhotic patients with spontaneous bacterial peritonitis and low risk of mortality non-treated with albumin. J Hepatol 2009;50:227A. (Abst)
17. Boldt J. Use of albumin: An update. Br J Anaesth 2010;104:276-84.
18. Cochrane Injuries Group Albumin Reviewers. Human albumin administration in critically ill patients: Systematic review of randomized controlled trials. BMJ 1998;317:235-40.
19. Fernandez J, Monteagudo J, Bargallo X, et al. A randomized unblinded pilot study comparing albumin versus hydroxyethyl starch in spontaneous bacterial peritonitis. Hepatology 2005;42:627-34. (Pubitemid 41233655)
20. Wong F. Volume expanders for spontaneous bacterial peritonitis: Are we comparing oranges with oranges? Hepatology 2005;42:533-5. (Pubitemid 41233644)
21. Gines A, Fernandez-Esparrach G, Monescillo A, et al. Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis. Gastroenterology 1996;111:1002-10. (Pubitemid 26327603)
22. Cartier M, Terg R, Lucero R, et al. Pilot study: Gelafundin (polygeline) 4% plus antibiotics in the treatment of high-risk cirrhotic patients with spontaneous bacterial peritonitis. Aliment Pharmacol Ther 2010;32:43-8.
23. Araujo A, Rossi G, Lopes A, Ness S, Ivares-da-Silva M. Effect of intravenous albumin (standard vs dose reduced regimen) on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis: A double blind randomized clinical trial - interim analysis of the alternate study (301). The Liver Meeting. Boston, Massachusetts, October 30 to November 3, 2009.